Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
The prolyl-hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasia
European Journal of Haematology, 10/14/09
Hatzimichael E et al. – The data suggest that the prolyl–hydroxylases may be a novel class of potential tumour suppressors in plasma cell neoplasia that warrant further investigation with regard to their potential utility as biomarkers. EGLN3 is also methylated at high frequency in B–cell lymphoma subtypes, implying that loss of EGLN3 is an important epigenetic event not only in plasma cell neoplasias but also in B–cell neoplasias.
Related Articles
Plasma cell toll-like receptor (TLR) expression differs from that of B cells, and plasma cell TLR triggering enhances immunoglobulin production
Immunology, 11/12/09
Relevance Score: 70%
Primary plasma cell leukemia
Cancer, 11/04/09
Relevance Score: 69%
B cells in autoimmunity
Arthritis Research & Therapy, 10/29/09
Relevance Score: 69%
Relationship between eosinophils and chronic endometritis
Human Pathology, 10/08/09
Relevance Score: 69%
Phenotypic and functional characterization of switch memory B cells from patients with oligoarticular juvenile idiopathic arthritis
Arthritis Research & Therapy, 10/06/09
Relevance Score: 69%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Decreased expression of KLF6 and its significance in gastric carcinoma
Medical Oncology, 12/17/09
The development of risk groups in men with metastatic castration-resistant prostate cancer based on risk factors for PSA decline and survival
European Journal of Cancer, 12/16/09
Expression of HIF-1alpha and VEGF in colorectal cancer: Association with clinical outcomes and prognostic implications
BMC Cancer, 12/15/09
Today in Leukemia/Lymphoma...keeping you current
Receive free subspecialty "5-minute updates" via email
A randomized, controlled, double-blind, pilot study of milk thistle for the treatment of hepatotoxicity in childhood acute lymphoblastic leukemia (ALL)
Cancer, 12/16/09
Vascular endothelial growth factor-C (VEGF-C) promotes angiogenesis by induction of COX-2 in leukemic cells via the VEGF-R3/JNK/AP-1 pathway
Carcinogenesis, 12/15/09
Nonpegylated liposomal doxorubicin (MyocetTM) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): Results from the phase II EUR018 trial
Annals of Oncology, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


